Table 1.
Characteristic | Cohort 1 (n = 45) | Cohort 2 (n = 20) | Total (n = 65) | |||
---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | |
Female sex | 20 | 44 | 14 | 70 | 34 | 52 |
Median age, y (range) | 31 (13-65) | 35 (19-59) | 33 (13-65) | |||
Stage at initial diagnosis | ||||||
Early | 22 | 49 | 13 | 65 | 35 | 54 |
Advanced | 23 | 51 | 7 | 35 | 30 | 46 |
Stage at relapse | ||||||
Early | 23 | 51 | 13 | 65 | 36 | 55 |
Advanced | 22 | 49 | 7 | 35 | 29 | 45 |
Refractory | 25 | 56 | 9 | 45 | 34 | 52 |
B symptoms | 9 | 20 | 1 | 5 | 10 | 15 |
Extranodal disease | 19 | 42 | 5 | 25 | 24 | 37 |
Bulk (>5 cm) | 12 | 27 | 4 | 20 | 16 | 25 |